Assessment of BPSD Rajesh Tampi , MD Professor of Psychiatry

Slides:

Advertisements

Similar presentations

Indianapolis Discovery Network for Dementia Comparative Effectiveness Research Trial of Alzheimers Disease Drug: COMET-AD.

Advertisements

Management of Behavioral and Psychological Symptoms in People with Dementia Living in Care Homes: A UK Perspective Clive Ballard Professor of Age Related.

The Three Ds of Confusion Delirium, Depression, Dementia

Supported by grants from: National Human Genome Research Institute (ELSI) HG/AG (The REVEAL Study); National Institute on Aging AG (The MIRAGE.

Neuropsychiatric Symptoms of Dementia Dr. Dallas Seitz MD FRCPC Assistant Professor, Department of Psychiatry Queen’s University.

The Right Prescription A Call to Action for junior doctors on the use of antipsychotic drugs for people with dementia.

RNFL Thickness. The ubiquitin proteasome pathway – PD genes Adapted from Eriksen et al Arch Neurol 2005, 6:

An exploratory study into the use of Reminiscence Therapy amongst people with dementia and their caregivers in Ireland. Treena Parsons - School of Social.

Psychiatric presentation of Alzheimer’s in Jordan Preliminary survey Jamal Khatib MD Consultant Psychiatrist Jordanian Alzheimer Association.

Dementia Patients Caregivers Quality of Life International Journal of Geriatric Psychiatry Karine Demeule.

M3 Seminar December “Geriatrics” in a Nutshell Karen E. Hall, M.D., Ph.D. Clinical Assistant Professor of Internal Medicine University of Michigan.

Criteria for Psychiatric Symptoms in Alzheimer’s Disease Clinical Trials Jeffrey L. Cummings, M.D. Alzheimer’s Disease Center UCLA School of Medicine FDA.

Center for Geriatric Health. Changing the Approach Olympia Medical Center has changed the approach to healthcare for the geriatric patient. This unique.

The National Task Group Early Detection Screen for Dementia

Geriatric psychiatry „Old age” psychiatry Zoltán Hidasi MD.

Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.

Indianapolis Discovery Network for Dementia Forecasting the Future Impact of Early Detection and Management Program for Alzheimer.

Indianapolis Discovery Network for Dementia Comparative Effectiveness Research Trial of Alzheimer’s Disease Drugs: COMET-AD.

Reduction Of Hospital Readmissions Hany Salama, MD Diplomat ABIM IM Hospice and Palliative Care Sleep Medicine.

Leslie Udell Program Co-ordinator Winnserv Inc.

Patient education tools are key to the follow- up of chronic heart failure patients.

Non-medication Management of Agitated Behavior in Dementia Patients Josepha A. Cheong, MD University of Florida Departments of Psychiatry and Neurology.

Best Practice Guide: Treatment and care for behavioural and psychological symptoms Clive Ballard, Anne Corbett, Alistair Burns Alzheimer’s Society UK.

Geriatric Psychiatry Services JoAnn Pelletier-Bressette, RN, Nurse Manager Nancy Hooper, BScN, RN, CPMHN (C) 1.

Alzheimer’s Disease Tessa Dillon Nova Southeastern University Clinical Genetics Teri Doolittle, PA-C, MHP, DHSc August 3, 2008.

COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.

ASSESSMENT OF QUALITY OF LIFE IN DEMENTIA: problems, methods and results Michel Ylieff Michel Ylieff Qualidem Research Group University of Liege (ULg)

Introduction: Medical Psychology and Border Areas

Alan Breier, M.D. Leader, Zyprexa Product Team Lilly Research Fellow Professor of Psychiatry, Indiana University School of Medicine Adjunct Associate of.

Alzheimer’s Disease  Goals  To understand what dementia is  To explore causes, risk factors, symptoms, and treatments of Alzheimer’s Disease  To better.

Anxiety Disorders in Older People George T. Grossberg, MD Samuel W. Fordyce Professor Director, Geriatric Psychiatry Saint Louis University School of Medicine.

CU-1 Summary of Neuropathological and Clinical Features of PDD Clive Ballard, MD Professor of Age Related Diseases Institute of Psychiatry King’s College.

Contributions to Inter-professional Practice Paul R. Gould, LCSW.

Copyright ©2007 The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Classification and Treatment Plans.

Duke GEC DELIRIUM What’s in a name? Duke Geriatric Education Center

Use of Antipsychotic Drugs in Dementia Josepha A. Cheong, MD University of Florida Departments of Psychiatry and Neurology Chief, Division of Geriatric.

Assessment and Diagnosis of Dementia Dr Alison Haddow.

Mary’s Care Needs Progress Mary’s dementia progressed and she now needs 24 hour residential care. She develops behavioural difficulties in residential.

 a type of dementia that causes problems with memory, thinking and behavior. Symptoms usually develop slowly and get worse over time, becoming severe.

Alternative approaches to behaviour that challenges Professor Bob Woods Dementia Services Development Centre Bangor University, Wales, UK

Effects of Memantine on behavioural symptoms in Alzheimer’s disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised,

Cognitive Development Dementia. Stages: Preclinical First sign: memory loss for the familiar First sign: memory loss for the familiar Biological changes.

Clarissa Kripke, MD, FAAFP Director Developmental Primary Care University of California, San Francisco Training Family Physicians to Improve Care for Adults.

Music therapy in moderate and severe dementia of Alzheimer’s type: a case-control study H.B. Svansdottir and J. Snaedal Geriatric Department, Landspitali.

DISEASES OF MENTAL STATUS AND ELDER ABUSE. Delirium  Disturbance of consciousness with deficits of attention and changes in cognition or perception that.

Chapter 10: Nursing Management of Dementia

Dement Geriatr Cogn Disord 2011;31:239– DOI: /

The behavioral pathology in Alzheimer's Disease Scale; BEHAVE-AD

CHILD PSYCHIATRY Fatima Al-Haidar

Incidence per 1000 man-years of BPH, as defined by LUTS plus a clinical diagnosis of BPH, medical therapy for BPH, or surgical treatment for BPH during.

#14-A-1124 AAN Department of Neurology and Epidemiology, University of Oklahoma Medical Center; Oklahoma City, OK Cognitive and Behavioral Changes in PSP:

“Advances in Psychiatry of Japan”

Poststroke dementia Vikas Dhikav,

Management of Agitation in Dementia

Clinical Spectrum, Risk Factors, and Behavioral Abnormalities among Dementia Subtypes in a North Indian Population: A Hospital-Based Study Dement Geriatr.

What is Dementia? A term that describes a wide range of symptoms associated with a decline in memory or other thinking skills. Dementia may be severe.

THE PREVALENCE OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA IN RURAL TANZANIA

Treatment of Clients Experiencing Anxiety

Assessing Opioid Use Disorder, part 1

Generalized Anxiety Disorder: Clinical Features and Diagnosis

Goals of Care Dr. P. Methvin, Langley Division of Family Practice

Epidemiology of Dementias

Neurobiology of BPSD Rajesh Tampi , MD Professor of Psychiatry

Reducing antibiotic use in influenza: challenges and rewards

Interreg-IPA Cross-border Cooperation Programme Romania-Serbia

Medical Approach Physicians began using medical models to review the physical causes of these disorders. Etiology: Cause and development of the disorder.

Chapter 25 The Elderly.

Interreg-IPA Cross-border Cooperation Programme Romania-Serbia

When to Submit a Urine Specimen for Testing?

Classification and Treatment Plans

Presentation transcript:

Assessment of BPSD Rajesh Tampi , MD Professor of Psychiatry Case Western Reserve University School of Medicine

Obtaining important collateral information Collateral information from caregivers and/or family members Robert PH,et al. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry. 2005;20(7):490-6.

Obtaining important collateral information Onset Course Differential diagnosis Risk and prognosis Collateral information from caregivers and/or family members Robert PH,et al. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry. 2005;20(7):490-6.

Obtaining important collateral information Environmental triggers Psychosocial stressors Collateral information from caregivers and/or family members Robert PH,et al. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry. 2005;20(7):490-6.

Rule out medical causes Pain syndromes Dehydration Urinary tract infections Robert PH,et al. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry. 2005;20(7):490-6.

Rule out medical causes Pain syndromes Dehydration Urinary tract infections Effective evaluation and management Reduction in frequency and severity of BPSD Robert PH,et al. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry. 2005;20(7):490-6.

Use of standardized assessments Used for: Rating severity Tracking progression of BPSD over time Monitoring response to treatment Jeon YH, Sansoni J, Low LF, et al. Recommended measures for the assessment of behavioral disturbances associated with dementia. Am J Geriatr Psychiatry. 2011 May;19(5):403-15.

Use of standardized assessments Examples NPI: Neuropsychiatric Inventory BEHAVE-AD: Behavioral Pathology in Alzheimer’s Disease Rating Scale CERAD-BRSD: Consortium to Establish a Registry for AD- Behavior Rating Scale for Dementia DBSS: Dementia Behavior Disturbance Scale Jeon YH, Sansoni J, Low LF, et al. Recommended measures for the assessment of behavioral disturbances associated with dementia. Am J Geriatr Psychiatry. 2011 May;19(5):403-15.

Use of standardized assessments Examples NPI: Neuropsychiatric Inventory BEHAVE-AD: Behavioral Pathology in Alzheimer’s Disease Rating Scale CERAD-BRSD: Consortium to Establish a Registry for AD- Behavior Rating Scale for Dementia DBSS: Dementia Behavior Disturbance Scale (Most popular and reliable assessment tool ) Jeon YH, Sansoni J, Low LF, et al. Recommended measures for the assessment of behavioral disturbances associated with dementia. Am J Geriatr Psychiatry. 2011 May;19(5):403-15.